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Standard operating procedure 
A B S T R A C T   
The EU human biomonitoring initiative, HBM4EU, aims to co-ordinate and advance human biomonitoring 
(HBM) across Europe. As part of HBM4EU, we presented a protocol for a multicentre study to characterize 
occupational exposure to hexavalent chromium (Cr(VI)) in nine European countries (HBM4EU chromates study). 
This study intended to collect data on current occupational exposure and to test new indicators for chromium 
(Cr) biomonitoring (Cr(VI) in exhaled breath condensate and Cr in red blood cells), in addition to traditional 
urinary total Cr analyses. Also, data from occupational hygiene samples and biomarkers of early biological ef-
fects, including genetic and epigenetic effects, was obtained, complementing the biomonitoring information. 
Data collection and analysis was completed, with the project findings being made separately available. As 
HBM4EU prepares to embark on further European wide biomonitoring studies, we considered it important to 
reflect on the experiences gained through our harmonised approach. Several practical aspects are highlighted for 
improvement in future studies, e.g., more thorough/earlier training on the implementation of standard operating 
procedures for field researchers, training on the use of the data entry template, as well as improved company 
communications. The HBM4EU chromates study team considered that the study had successfully demonstrated 
the feasibility of conducting a harmonised multicentre investigation able to achieve the research aims and ob-
jectives. This was largely attributable to the engaged multidisciplinary network, committed to deliver clearly 
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understood goals. Such networks take time and investment to develop, but are priceless in terms of their ability 
to deliver and facilitate knowledge sharing and collaboration.   
1. Introduction 
By revealing internal exposure and early effects in the human body, 
human biomonitoring (HBM) can provide an invaluable contribution for 
public health decision-making based on the risk assessment of chem-
icals. HBM has been considered as a relevant approach for the health risk 
management, e.g. under EU REACH regulation (Boogaard et al., 2011) 
and provides relevant information to support policy development by 
delivering better evidence of workers’ exposure to chemical substances 
in the scope of different regulatory frameworks (Viegas et al., 2020; 
Jones, 2020). Both the general population (exposed through environ-
ment) and workers (occupationally exposed), can benefit from the use of 
data generated by HBM studies, but further harmonisation and stan-
dardization of methodologies is necessary to improve and refine such 
assessments (Louro et al., 2019). 
The EU human biomonitoring initiative (HBM4EU) is a Joint Pro-
gramme that aims to standardise and use biomonitoring to understand 
human exposure to chemicals (via the environment, in occupational 
settings or through using consumer products) and the related health 
risks, with the aim to improve chemical risk assessment and manage-
ment as well as to support policymaking (Ganzleben et al., 2017). 
HBM4EU is a joint effort of 30 countries, the European Environment 
Agency and the European Commission, co-funded under Horizon 2020 
(www.hbm4eu.eu). 
Occupational health has a long tradition of using HBM to control 
worker’s exposure. The use of HBM in occupational settings can serve as 
a model system to implement and improve HBM approaches that can be 
expanded to environmental exposure in the general population. More 
research in best practices and procedures for occupational HBM was to 
be addressed within the remit of the HBM4EU project as various chal-
lenges still present themselves. Typically, a limited number of workers 
can be, and are, recruited into national studies. Furthermore, the studies 
performed by different researchers in individual countries are usually 
not aligned with respect to sampling/analytical methodologies or the 
collection of contextual data, which complicates the comparison of the 
findings and use of the data in regulatory risk assessment at a European 
or international level. Combining national surveys using harmonised 
study designs, methodologies and protocols can potentially greatly 
improve the information collected and provide the benefit of harmon-
ised data collected in different countries, as demonstrated in the earlier 
DEMOCOPHES project (Den Hond et al., 2015). 
One of the most important aims of the overall HBM4EU project is the 
harmonisation of methodologies and standardized collection of the data 
useful for EU decision making. In line with this aim, we previously 
presented a multicentre study that intended to characterize occupational 
exposure to hexavalent chromium (Cr(VI)) in industrial settings across 
Europe (Santonen et al., 2019). Examples of industrial activities that are 
sources of workers exposure comprise welding, electroplating, surfaces 
treatment and leather tanning (Elhosary et al., 2014; Lin et al., 2018; 
Pan et al., 2018; Wang et al., 2012). The main exposure routes are 
dermal contact, inhalation of dust and mist or fumes, and ingestion due 
to hand-mouth contact. Despite its carcinogenicity, the use of Cr(VI) 
compounds (chromates, chromium trioxide and dichromium tris(chro-
mate)) for specific purposes is still authorized under the European 
regulation (EC, 1907/2006) concerning the Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH) and thereby still 
raises concern. The main adverse health outcomes due to chronic Cr(VI) 
inhalation are lung impairment, including pneumonia, bronchitis, 
asthma and lung cancer (IARC, 2012). This study also aimed to inves-
tigate the relationship between biomarkers of exposure, environmental 
monitoring and biomarkers of effect and to recognise how all these tools 
add to occupational exposure, risk assessment and management pro-
cesses. Although a number of studies has reported data on human 
exposure to Cr(VI), comparably fewer have included effect biomarkers 
analysis. As Cr(VI) is a direct and indirect (through reactive oxygen 
species production) genotoxic metal (Chen et al., 2019), the effect bio-
markers included were associated with oxidative stress and DNA or 
chromosome damage (Li et al., 2014; Pan et al., 2018). In addition, 
following innovative methodologies development, omics-based bio-
markers were also analysed. Furthermore, it is expected that the data 
generated may be used to address questions, for example, related to the 
efficacy of the regulatory measures already implemented, as well as 
allowing for the identification for further actions. In this contribution, 
we reflect on the experiences gained from undertaking this study so that 
lessons can be learnt and shared with the wider scientific community 
and can be considered when developing future occupational multicentre 
studies. 
2. Materials and methods 
The HBM4EU chromates study team participated in a number of 
activities to design, harmonise and undertake this multicentre study, the 
key ones of which are summarized in Fig. 1. It is important to highlight 
that whilst presented as a workflow, the events were not always 
sequential, with several of the activities occurring in parallel (e.g. 
company identification and company/worker recruitment and sample 
and data collection; data entry and cleaning and sample analysis). It is 
also essential to highlight the several overarching activities that took 
place across the different elements of the work program. For example, 
there was extensive quality assurance and quality control round robins 
for the biological sample analysis aspects. The HBM4EU chromates 
study core network expanded during the course of the study to include 
further researchers to collect the field samples and contextual data, 
additional scientists to process and analyse the collected samples, to 
analyse cytogenetic and molecular effect biomarkers, etc. Finally, there 
were extensive communications within the project team via web con-
ferences, email correspondence to discuss the work programme as it 
progressed and evolved. 
It was important for the HBM4EU chromates study project team to 
reflect on the research and evaluate both the positives and limitations of 
the harmonised approach that was developed and applied. Following 
completion of the data gathering and processing elements of the work, 
members of the project team were asked, via email, to provide feedback 
on three things that went well with the study and three things that were 
felt could be improved upon. The responses provided were used to 
facilitate an open discussion during a session at the 4th HBM4EU 
training school, May 14, 2020. Here, participants were able to identify 
any additional points that they wished to raise as well as discuss how the 
project team could learn from the experiences gained to inform the 
future HMB4EU occupational multicentre studies, focussed on diiso-
cyanates and electronic waste management sectors. Additional input 
was provided during the drafting of HBM4EU deliverables, various 
project team meetings, with further contributions being provided by the 
(co-) authors during the drafting of this manuscript. The information 
gathered from these various initiatives is summarized in the following 
sections, categorized under two broad groups: (i) What were the suc-
cesses and benefits? (ii) What were the issues encountered and suggested 
improvements? For the second group, the views are divided into several 
topics; these being ethics and General Data Protection Regulation 
(GDPR); standard operating procedures (SOPs); sample collection; 
sample analysis; data reporting, input and analysis; and communication. 
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3. Results and discussion 
It should be firstly highlighted that undertaking a complex multi-
centre study takes a great deal of time and effort and this should not be 
underestimated. The research plan for the HBM4EU chromates study 
was published as a HBM4EU Deliverable report in December 2017 
(Ndaw et al., 2017), with development of the core chromates study team 
and discussions to develop the project plan taking place well in advance 
of this. The development of the SOPs started in February 2018 and 
continued until the end of 2018, since some of the SOPs were identified 
as requiring refining/clarification after the first site visits occurred in 
November 2018. The field measurement campaigns started in most 
countries at the end of 2018 and progressed through to the later part of 
2019. Data analysis and reporting is still ongoing at the time of drafting 
this manuscript (end 2020) and will continue until at least early 2021. 
3.1. What were the successes and benefits of the HBM4EU chromates 
study? 
A number of successes and benefits through adopting the harmonised 
approach in the HBM4EU chromates study were identified. From a 
project perspective, that is, in terms of achieving the study aims and 
objectives, the harmonised approach has provided new information on 
the usefulness of new biomarkers for the monitoring of Cr(VI) exposure 
to be generated. 
In the research protocol, the target sample numbers for exposed 
workers were 50 workers per country, aiming to collect 100 urine (two 
samples per worker), 25 blood and 50 exhaled breath condensate (EBC) 
samples (from 25 workers, each providing two samples) per country. In 
addition, 25 controls were to be recruited in each country, each 
providing one urine, blood and EBC sample (Santonen et al., 2019). In 
the research protocol eight countries were to participate in the HBM4EU 
chromates study, however the National Health Laboratory (LNS), 
together with the Multisectoral Occupational Health Service (STM) of 
the Ministry of Health in Luxembourg were able to implement the pro-
tocol at a later stage, recruiting several welding companies, with their 
data being included in the HBM4EU chromates study. Thus the country 
participation increased to nine. 
Forty-four companies were recruited for which exposed workers 
consented to participate in the study. Some of our control population 
were recruited in, for example, office staff in these companies although 
three additional companies were also recruited. 399 exposed workers 
and 203 controls were enrolled into the study, which was very close or in 
excess of our respective targets of 400 workers and 200 controls 
(>99.75% of targets achieved). 
For the exposed workers, a total of 780 urine samples (397 pre-shift 
and 383 post-shift), 345 blood samples and 342 EBC samples were 
collected (167 pre-shift and 175 post-shift). Concerning the control 
population, a total of 143 urine, 175 blood and 98 EBC samples were 
obtained. Whilst the numbers of some sample types collected were 
slightly lower than the overall target, this was due to some countries 
electing to not collect particular samples (e.g., the UK did not collect 
blood samples, Poland and Luxembourg did not collect EBC samples, 
and the UK and Italy did not collect urine samples from the controls). In 
addition, 25 air and 25 sets of dermal wipe samples were to be collected 
per country (the aim being to collect these samples from half of the 
participating workers). 293 inhalable (218 collected outside RPE and 75 
inside RPE respectively) and 155 respirable samples were collected, with 
270 sets of dermal samples being collected, which exceeded our target. 
The number of participants and samples collected from the nine 
involved countries allowed us to achieve the required statistical power 
for the study (Santonen et al., 2019) and obtain a more comprehensive 
and richer dataset to inform regulatory and policy agencies in the EU, as 
well as further scientific investigation when compared to (smaller) na-
tional studies. Field work also allowed us to engage workers, companies 
and to generate awareness for the need to control exposure to Cr(VI) in 
the investigated occupational sectors across Europe, as well as for the 
HBM4EU study at both National and International level. 
Fig. 1. Key activities in the design and implementation of the HBM4EU chromates study.  
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The study served also as a valued ‘educational tool’, where several 
lessons were learnt concerning the conduct of aligned, multicentre 
occupational studies (which will be discussed in the following sections). 
It was also reflected that the effort put into the development of the 
harmonised process in the HBM4EU chromates study would make the 
process easier for subsequent occupational monitoring campaigns, for 
example, in HMB4EU and in future projects, as many of the SOPs, ma-
terials and ethical procedures can be reused, updated or adapted if 
needed. 
Other researchers and practitioners in the field of the scientific dis-
ciplines involved can also benefit from the harmonised efforts through 
applying the freely available SOPs (and materials which these contain) 
(Porras et al., 2019) to their own studies focused on Cr(VI). This will 
allow the potential of future data to be collected in the same standard-
ized manner, thus allowing opportunities for data pooling, identify 
exposure trends, comparisons between different risk management 
measures available etc. to be undertaken. As already mentioned, this 
opportunity has already been exploited through the inclusion of data 
collected in accordance with the study protocol in Luxembourg. 
It was clear that researchers involved in the study recognised that 
these successes were achieved through the valued and close co- 
operation between the participating institutions and researchers from 
the different countries, who were all focused and working together to-
wards clearly defined aims and objectives. The core project network 
worked extremely well together and were personally committed and 
invested in maximizing the successes of the overall project. It was also 
observed that members of the HBM4EU chromates study network have 
continued to build and expand their relationships and networks through 
other biomonitoring networks (e.g., ISES-Europe working group, OECD 
Working Party on Hazard Assessment (WPHA) and Working Party on 
Exposure Assessment (WPEA)). These only serve to increase further the 
benefits to the scientific and regulatory communities, where exposure 
data and science are of paramount relevance. 
3.2. What were the issues encountered and suggested improvements? 
Despite adopting a harmonised and consistent approach and the time 
and effort that was invested into this, issues were encountered and 
raised. For ease, these have been grouped under several key themes, 
these being: ethics and GDPR; SOPs; sample collection; sample analysis; 
data reporting, input and analysis; and communication. 
3.3. Ethics and GDPR 
The management of a biobank and accompanying transport of bio-
logical samples within the context of an international occupational 
study is regulated by national, European and international regulation 
(Knudsen and Faber., 2018a). The variation and fragmentation of these 
biobank regulations and the consequently need for more harmonisation 
and standardization was the main conclusion of a report (Gottweis et al., 
2012) published by the European Commission. One of such regulatory 
requirements concerning biobank practises is that the transport of bio-
logical samples between research partners takes place under material 
transfer agreements (MTAs) (Cervo et al., 2016). The restrictions and 
obligations of these MTAs doesn’t only apply to primary sample (or 
parent sample), but also to (post-) interventions made using the primary 
sample and/or to derivative samples (Bennett et al., 2007). The frag-
mentation of the regulation in combination with the growing regulatory 
requirements, makes it more difficult to freely transfer biological sam-
ples between research partners. Therefore, international harmonisation 
and standardization of the biobank practices is required within the 
context of an international occupational study. 
Ethics is a national issue. However to comply with EU regulations, 
special attention must be given towards data protection with respect to 
the GDPR regulation (Knudsen and Faber., 2018b). This regulation sets 
requirements for information to participants about confidentiality 
measures, as well as requirements for the investigators to secure data. 
Data handling was organised locally with pseudonymised data for-
warded to the central data management. Mutual data transfer agree-
ments were signed and a parallel system was put in place for sample 
transfers. Prior to submission to National Ethics committees, a standard 
protocol with information sheets, consent forms etc was developed and 
implemented. To comply with the GDPR the participants were informed 
about such transfers and the protocol and information sheets provided 
explanations and details. 
It was evident from the feedback of the various ethics committees 
that they would often highlight different points for further clarification 
and for the local project team to respond to, e.g., request to clarify what 
is meant by ‘DNA damage’ and addition of a question for the study 
participant to agree for unexpected results to be shared with their gen-
eral practitioner. A separate ethics committee also raised the point that 
workers with ‘elevated’ results may be worried and request clarification 
on what is considered as being unsafe, undesirable levels. In the worker 
participant information sheet, we emphasised that biological moni-
toring is a measurement of exposure only and not a measurement of ill 
health and that when participants received their results, we would 
provide an interpretation on whether these were elevated or not. The 
above comments led to the ethics committee requesting to see an 
example results letter outlining the different example sentences for each 
potential scenario (e.g. within the background reference range, above 
the reference range but less than the guidance value and above the 
guidance value). Another ethics committee requested that clarification 
in the text on what was being studied now; in the future and to what, 
exactly, participants need to give their consent to. A further Ethics Board 
requested the information and consent forms to be provided in further 
languages if appropriate and necessary (e.g. Swedish as well as Finnish). 
The lessons learned from an ethics and GDPR perspective are that 
these are two critical and essential aspects of the study design but that it 
can be quite time consuming to have everything put in place, submitted, 
reviewed, responded to and finally agreed, which clearly can then affect 
timescales for the following phases of the project. Different ethics 
committees may highlight different attributes of the application and 
materials for clarification and moving on it is important to synthesize 
these to establish what the commonalities are so that these can be 
addressed in subsequent ethics applications at an early stage. The 
approach adopted for the HBM4EU chromates study was to recruit 
companies to participate in the campaign and for the team to then invite 
their workers to participate. One ethics board highlighted that to secure 
a free choice by the worker to participate, the invitation to participate 
should be sent out by the researcher to the employees directly (without 
any intervention of employer) as their decision making may be influ-
enced, either positive or negatively in this manner. This is an important 
point to consider for future studies, although perhaps very difficult to 
achieve in practice. 
3.4. SOPs 
Table 1 lists the SOPs prepared for the HBM4EU chromates study, 
which are freely available at the online library of the HBM4EU website 
((Porras et al., 2019, https://www.hbm4eu.eu/online-library/). The 
SOPs used in the campaign were developed following an extensive 
drafting period, with input from many researchers across the project 
team. The procedures outlined in the SOPs were also delivered as part of 
a training school, which allowed participants to identify any areas of 
uncertainty, etc. However, in some cases, it was evident that the field 
researchers, those who needed to fully understand and apply the con-
tents of the SOPs, had not been involved in these earlier discussions. This 
resulted in some last-minute modifications on SOPs taking place 
following the start of the sampling campaigns, which is not desirable. 
It was highlighted that SOPs were only available in English, not in 
the local languages of the other European countries involved in the 
campaign. Whilst it was reflected that this was not an issue for the 
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HBM4EU chromates study team it may have been for some of the field 
researchers, particularly with some of the more technically demanding 
language used. It was mentioned that in at least one instance the field 
researchers translated a SOP into their native language themselves so 
that they were more comfortable with their understanding of what was 
needed to be done. It was also considered that sample transfer details 
(list of labs and contract details) should have been included in the SOPs, 
rather than separately. 
The lessons learned from the development of the SOPs is that the 
time and effort involved in this activity should never be underestimated 
by researchers, and that, even despite this, last minute, issues do crop 
up. It is therefore essential that those involved in implementing the SOPs 
(i.e. the field researchers) are involved in the finalization of these doc-
uments. Whilst a training school was held for the HBM4EU chromates 
study, not all researchers involved in the fieldwork were able to 
participate and different local training regimes were likely to have been 
implemented in the various countries. More effort should be made to run 
centralized training sessions, for example via webinars, well in advance 
of the monitoring campaigns commencing so that common questions 
and uncertainties can be promptly addressed. If SOPs are to be translated 
into local languages for future studies there would be a need to verify 
that the translation is indeed correct. 
3.5. Sample collection 
Field work to collect all the samples and contextual data was high-
lighted to be more time consuming than anticipated (by both the field 
researchers and the participating workers). It was considered that 
completion of the detailed worker questionnaires and collecting all of 
the necessary samples may have, in some instances, reduced the effec-
tive working time during the sampling day. In addition, a significant 
number of the participating companies were small in size, with low 
numbers of workers who were actually eligible to participate in each. 
Therefore, any reduction in working time for the participants may have 
a significant impact on the company’s productivity. Also, due to the fact 
that companies were smaller in size than expected, more time and effort 
was spent to identify, visit and recruit additional companies reach the 
target number of study participants (and obtain their corresponding 
samples). Exposures in SMEs are important to understand and often 
overlooked precisely for the reasons just mentioned. 
Specific issues were noted with respect to the worker and company 
questionnaires, with these cited as being too long or short and the 
collection of the EBC samples were also highlighted as being time 
consuming. It was highlighted that, where possible, all samplings 
(excluding pre-shift) should be done as close as possible to the end of the 
shift (preferably post-shift). However it was also recognised that this 
may not be possible due to numbers of workers involved and their desire 
to leave work promptly following completion of their work shift. 
Despite the SOPs, there were some variations in procedures that were 
followed. For example, air sampling pumps were not always switched off 
during the breaks and there was variability in the sample types 
collected, with some diversity of air samples being collected depending 
on the job being undertaken. In one country, only inhalable (total) dust 
samples were collected, whereas in the other countries both inhalable 
and respirable dust samples were collected (as per SOP). There was also 
some variability in the positioning of samples, despite instructions being 
given in the SOP that samples were to be collected from the breathing 
zone area, except for those collected from welding operators where these 
were to be inside the welding helmet. For example, some countries 
collected samples outside the RPE (in the breathing zone) whereas 
others collected samples both inside and outside of the RPE. In one 
country only pre-shift and end shift dermal wipe samples were collected 
although it was instructed to also collect samples before break periods. 
EBC-Cr(VI) is a new biomarker-matrix combination which has been 
used only once before (Leese et al., 2017) in occupational biomonitoring 
study. Some EBC results were obtained, which were then excluded from 
the data analysis (high Cr(III) levels which questioned the reliability of 
the Cr(VI) results) which was considered to be due to different com-
plexing (EDTA) solutions being used or contaminated glassware. 
One of the lessons learned from the sample collection is that it was 
more time consuming than anticipated. The HBM4EU chromates study 
was very ambitious, collecting a wealth of biomonitoring, occupational 
hygiene samples and supporting questionnaire and contextual data so to 
achieve its aims and objectives. However, consideration must always be 
given to the impact that such sampling strategies have on company/ 
worker participation and their working practices, numbers of field 
workers required to ensure efficient sample collection etc. Engagement 
and recruitment of SMEs into exposure monitoring campaigns is 
particularly challenging and sufficient time and resources must be 
allocated to this. Overall, sample and data collection were in adherence 
with the SOPs focussed on the biological samples, with deviations 
occurring in some instances with the occupational hygiene samples. 
Whilst the study was focussed primarily on HBM, the occupational hy-
giene samples served an important role in the study and so it is impor-
tant that the same level of robustness and rigour be given to these 
samples. Ensuring that more structured training of the field researchers 
Table 1 
List of detailed SOPs prepared for the HBM4EU chromates study (Santonen et al., 
2019), with additional information on the laboratory analysis undertaken for the 






1 Standard operating 
procedure for selection 
of participants and 
recruitment, 






2 Standard operating 
procedure for 
completion of 






3 Standard operating 
procedure for blood 
sampling, including 
sample storage and 
transfer 
Blood RBC – Cr; Plasma – Cr, 
Plasma-PFAS; Whole 
blood - Micronucleus & 
Comet assays, Epigenetics; 
Reticulocytes - 
Micronucleus assay 
4 Standard operating 
procedure for the 
collection of exhaled 
breath condensate 
samples 
EBC Cr(VI) and Cr(III); Ni and 
Mn 
5 Standard operating 
procedure for urine 
sampling, including 
sample storage and 
transfer 
Urine Total Cr, Ni, Mn, oxidative 




6 Standard operating 
procedure for air 
sampling of inhalable 




Air Total Cr, Cr(VI) 
7 Standard operating 
procedure for 
obtaining dermal wipe 
samples 
Dermal Total Cr 
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takes place prior to commencing the sampling campaigns may help 
address this. Concerning effect biomarkers analysis, it is important to 
ensure that samples reach the laboratory in a short period of time after 
collection, particularly, if blood cells must be immediately processed 
upon arrival (e.g., lymphocytes cultures for micronucleus analysis in 
blood lymphocytes). Although it is trivial to transfer biological samples 
among laboratories, it must be stressed that adequate packaging and 
transportation conditions (e.g. temperature) have to be ensured to not 
compromise the success of the analyses. 
3.6. Data reporting, input and analysis 
A MS Excel data template was circulated for researchers to input data 
and results obtained from the chromates study. This data template was 
very large so to facilitate entry and transfer of all data collected under 
the HBM4EU chromates study SOPs. Templates of such a size can in 
advertently lead to data entry errors occurring and so those populating 
the files needed a great deal of care and diligence. 
In most cases, the HBM4EU chromates data template was populated 
according to given instructions. However, there were many exceptions, 
and it was evident that some researchers had difficulties with 
completing the template and there was variation in how this was done. 
For example, despite requesting that work task and overall work dura-
tion be given in hours, it was often given in minutes (sometimes with 
units included, other times not). On occasions entries asked for the data 
user to refer to other lines of information or indeed merged cells (e.g., 
free description of the workplace of all workers in the same company) 
which added time and effort to the data cleaning process. On a few 
occasions, it was apparent that details of the weekly work schedule were 
provided rather than details of the work tasks actually undertaken 
during the measurement period. Despite the inclusion of drop-down lists 
to facilitate data entry (e.g. for local exhaust ventilation and respiratory 
protection equipment), these were not always used and instead were 
manually removed by those inputting data and replaced with free text 
data. In response to the question, “If other tasks were done during the 
measuring day, please specify here (free text)”, often an entry of ‘yes’ 
was assigned, with no additional information provided. Less commonly, 
answers were provided which did not relate to the question being 
responded to. Some of these issues were perhaps due to the fact that the 
individual SOPs developed for the study did not cover data reporting, 
and there was no overarching SOP covering this aspect. Whilst in-
structions were provided separately by email to researchers concerning 
many of these points (and others) to assist with the data entry process, 
these were not always considered. This resulted in significantly more 
time being taken to check, verify and clean the results before data 
analysis could commence. 
Limit of Quantification (LOQs) varied in different laboratories, 
which may have had an impact on the results of, for example, EBC Cr(VI) 
measurements since the levels in controls and workers were often low. 
The verification of LOQs in each country for all sample matrices should 
have been done before the study began in order to assess the potential 
impact of possible differences and to consider options for limit the 
impact of these differences. 
There were some deviations in the analysis undertaken for the 
collected occupational hygiene samples. The overarching focus of the 
study was on the biomonitoring sampling and analysis with extensive 
QC and QA procedures being put in place for this. Whilst efforts were 
made to harmonise the occupational hygiene sample collection, with 
details of the analytical methods to be used for analyzing the collected 
samples being included in the SOPs, the sample analysis was not part of 
the formal QC/QA programme. Despite the SOP stating that all air 
samples were to be analysed for both total Cr and Cr(VI), only five of the 
participating countries did so. 
Some differences in the biomonitoring analysis did however occur. 
Although this was a chromates study, blood, urine and EBC samples 
were also analysed for nickel and manganese. For example, urinary 
nickel levels were suggested to be analysed for welders and those platers 
performing nickel plating; urinary manganese levels were suggested to 
be analysed for stainless steel welders; however, this did not always take 
place. 
An important but still overlooked issue is that of the control group 
selection. In the majority of occupational studies reporting HBM data the 
control group consists of administrative workers from the same industry 
where exposed workers were selected. It is assumed that those workers, 
while performing their activities in an office, are not exposed to the 
occupational chemicals under study. Preliminary data from this study 
showed, however, that some individuals from the so-called “non- 
exposed group” are indeed exposed to low concentrations of Cr(VI), 
possibly present in the ambient air or even in surfaces of common spaces 
like canteens. Therefore, a double lesson is learnt from this knowledge: 
on one hand, controls outside the industry should be included in occu-
pational studies involving emissions of chemicals that may persist in the 
air and surfaces and, on the other hand, administrative workers must 
also be followed by the occupational health services as potentially 
exposed workers if HBM data is not available for them. 
The lessons learned from the data reporting, input and analysis were 
as follows. It is necessary to have a central tool in which to input data 
collected from such studies; however, it is essential that this tool is 
useable and clearly understood by those that need to populate it. It is 
necessary to hold training sessions with those that will be required to 
populate the tool so that they are familiarized with this and the data 
entry process (for both contextual and numerical data) that they must 
follow. It should be agreed by all involved that the tool will be used as 
per instructions and that, in the event that the template is unofficially 
modified or data are not input correctly, it will be returned to the pro-
vider to be corrected and amended. This agreement will ensure that the 
instructions are followed as well as reduce time spent on data checking 
and data cleaning step. The tool must be accompanied by text in each of 
the SOPs focused on data reporting for those particular aspects of the 
study. This text should detail how data entry should be undertaken, how 
calculations should be undertaken (where necessary), with examples 
given so to assist those in the tool completion and ensure that this is 
carried out in a standardised manner. Where possible the tool should be 
modified to allow for ease of entry and for key aspects to be highlighted 
to assist data interpretation e.g. flag data below LOQ or possible outliers. 
It was also apparent that much more instruction with respect to the 
collection and analysis of the occupational hygiene is warranted and 
that appropriate QA/QC for these samples should also be included 
within the programme of work. 
3.7. Communication 
The HBM4EU chromates study involved numerous companies and 
participants, with the project team having a wealth of knowledge and 
experience in undertaking occupational site work. However, challenges 
still presented themselves when completing the work. Some countries 
reported difficulties with engagement with companies and workers, 
with challenges being experienced with receiving clear information on 
the activities being undertaken from the companies’ representative. 
There were also several instances where field researchers arrived on site 
to undertake sampling to discover that the workers were not under-
taking any work where Cr(VI) exposure may occur, e.g. in some cases 
welders welded mostly mild steel instead of stainless steel; fewer 
workers than originally communicated were to be involved, or processes 
were not operating due to maintenance. These are common problems in 
industrial hygiene studies and the risks could be minimised by obtaining 
more accurate communication with the company representatives to 
ensure that the information they provide has reflects input from site 
supervisors, foreman, etc., who are more integrally involved in the ac-
tivities of interest and their daily production regimes. 
It was also important that due care and consideration be given to 
communicating the results of the study to the participating workers, 
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companies and wider stakeholders. Communication of the company 
specific data to participating companies was the responsibility of the 
each participating institute, according to their national/standard prac-
tises, with information leaflets also being provided. 
The HBM4EU chromates study team however reflected that more 
consideration needed to be given to the development of a dissemination 
plan for the wider communications of the project findings. 
Whilst the core project team itself communicated extensively via web 
conferences, email exchanges, training schools etc., it was still evident 
that communications were perhaps not always reaching those who also 
needed to receive it (e.g. training for all the field researchers). 
The major lesson learned is that good, clear communication net-
works must be established with those involved in multicentre studies, 
whether these be the project team itself, potential and actual partici-
pants and other stakeholders. For the second European wide occupa-
tional measurement campaigns, additional SOPs focused specifically on 
communication, covering whom, how and when, have been put in place. 
4. Conclusion 
The HBM4EU chromates study team held honest and frank discus-
sions when reflecting on the experiences gained from undertaking this 
study and considered it important to communicate these to the wider 
scientific audience so that others can learn from these too. Occupational 
studies such as the HBM4EU chromates study are scarce in terms of their 
breadth of scope and number of countries involved. Overall, even 
though there is room for improvements, the HMB4EU chromates study 
showed that it was feasible to conduct a pan-European occupational 
study in a consistent and concerted way and it’s hoped that other 
research teams can draw upon these experiences. Many of the lessons 
learned by the HBM4EU chromates team may not be new, or may even 
be considered as being trivial in nature. For example, Fiddicke et al. 
(2015) also observed that a biomonitoring survey involving many Eu-
ropean countries needs time for preparation and conduct and that 
extensive communication with potential participants (school-aged 
children in this instance) was necessary. For example, the importance of 
the method used to report non-detects was just one of the points high-
lighted during a workshop regarding biomonitoring study design, 
interpretation, and communication (Bates et al., 2005). However, this 
does not negate their importance or the need to reinforce to the wider 
scientific community that such aspects must be considered and factored 
into the project planning. Despite the points noted here, the data 
generated allows for a more robust assessment of exposure in different 
occupational settings and countries. The high number of data collected 
in turn will allow for more detailed data analysis that can provide more 
definitive answers to policy questions and recommendations for future 
studies aiming to address occupational exposure to Cr(VI). Furthermore, 
the findings of our study can be useful to define more adequate occu-
pational exposure limits and support regulatory action. It is likely that 
the study will result in several publications that will prove useful for 
stakeholders, from the regulatory field to occupational health services, 
with any relevant limitations to the data set (e.g. due to differences in 
sample collection, analysis) being highlighted. The true collaborative 
nature of the HBM4EU chromates study team allowed for open and frank 
discussion on the issues encountered, has increased our awareness on 
additional differences in the standard practises used in different coun-
tries/laboratories, and may result in further harmonisation of practises 
between labs/countries. All of the points raised for improvement have 
been considered and taken forward to improve the SOPs for the future 
HBM4EU occupational studies focussed on diisocyanates and electronic 
waste management, which are planned to start sampling in 2021. 
Furthermore, additional training schools were delivered during Jan 
2021 to communicate these to those researchers involved in the field-
work, which were also recorded so that they can be made available to 
any additional fieldworkers. 
Harmonisation is difficult to achieve and it is inevitable that it can 
always be improved upon, but it can be facilitated by having a solid 
network in place to enable this. However, development of such a strong 
successful network takes effort and engagement from all and it is 
important to ensure that adequate time, effort, resources is given for 
such an initiative. It is also a continual process whereby the team learns, 
shares, evolves from the experiences, and lessons gained. It is very much 
hoped that the lessons learned highlighted in this manuscript will be of 
value to researchers planning similar studies. 
Disclaimer 
The contents, including any opinions and/or conclusions expressed 
of this manuscript, are those of the authors alone and do not necessarily 
reflect the opinions or policy of the organizations to which they are 
employed. 
Declaration of competing interest 
No conflicts of interest are declared. 
Acknowledgements 
This project has received funding from the European Union’s Hori-
zon 2020 research and innovation programme under grant agreement 
No 733032 and received co-funding from the author’s organizations 
and/or Ministries. 
The project team would like to thank all the companies and workers 
who participated in the HBM4EU chromates study, as well as the wider 
research teams involved in the development, execution and reporting of 
this multicentre occupational biomonitoring campaign. 
References 
Bennett, A.B., Streitz, W.D., Gacel, R.A., 2007. Specific issues with material transfer 
agreements. In: Krattiger, A., Mahoney, R.T., Nelson, L., et al. (Eds.), Intellectual 
Property Management in Health and Agricultural Innovation: A Handbook of Best 
Practices. MIHR: Oxford, UK and PIPRA, Davis, USA. Available from: URL. http 
://www.iphandbook.org/handbook/ch07/p03/index_print.html. (Accessed 14 
November 2020).  
Bates, M.N., Hamilton, J.W., LaKind, J.S., Langenberg, P., O’Malley, M., Snodgrass, W., 
2005. Workgroup Report: biomonitoring study design, interpretation, and 
communication—lessons learned and path forward. Environ. Health Perspect. 113, 
1615–1621. 
Boogaard, P.J., Hays, S.M., Aylward, L.L., 2011. Human biomonitoring as a pragmatic 
tool to support health risk management of chemicals - examples under the EU 
REACH programme. Regul. Toxicol. Pharmacol. 59, 125–132. 
Cervo, S., De Paoli, P., Mestroni, E., Perin, T., Escoffier, L., Canzonieri, V., Steffan, A., 
2016. Drafting biological material transfer agreement: a ready-to-sign model for 
biobanks and biorepositories. Int. J. Biol. Markers 31 (2), 211–217. 
Chen, Q.Y., DesMarais, T., Costa, M., 2019. Metals and mechanisms of carcinogenesis. 
Annu. Rev. Pharmacol. Toxicol. 59, 537–554. 
Den Hond, E., Govarts, E., Willems, H., Smolders, R., Casteleyn, L., Kolossa-Gehring, M., 
Schwedler, G., Seiwert, M., Fiddicke, U., Castaño, A., Esteban, M., Angerer, J., 
Koch, H.M., Schindler, B.K., Sepai, O., Exley, K., Bloemen, L., Horvat, M., 
Knudsen, L.E., Joas, A., Joas, R., Biot, P., Aerts, D., Koppen, G., Katsonouri, A., 
Hadjipanayis, A., Krskova, A., Maly, M., Mørck, T.A., Rudnai, P., Kozepesy, S., 
Mulcahy, M., Mannion, R., Gutleb, A.C., Fischer, M.E., Ligocka, D., Jakubowski, M., 
Reis, M.F., Namorado, S., Gurzau, A.E., Lupsa, I.R., Halzlova, K., Jajcaj, M., 
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